Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03428958 |
Title | A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment |
Recruitment | Completed |
Gender | |
Phase | Phase I |
Variant Requirements | No |
Sponsors | NuCana plc |
Indications | |
Therapies | |
Age Groups: | |
Covered Countries | USA | GBR | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
Vanderbilt University | Nashville | Tennessee | 37232 | United States | Details | |
Seattle Cancer Center | Seattle | Washington | 98109-1023 | United States | Details | |
Compass Oncology | Vancouver | Washington | 98684 | United States | Details | |
Hopital Franco-Britannique | Levallois-Perret | 92300 | France | Details | ||
The Beatson West of Scotland Cancer Centre | Glasgow | G12 0YN | United Kingdom | Details | ||
University College London Hospitals NHS Foundation Trust | London | W1T 7HA | United Kingdom | Details | ||
University of Oxford | Oxford | OX3 7LE | United Kingdom | Details |